{"id":"champix","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[],"contraindications":["Acute coronary syndrome","Acute nephropathy","Aggressive behavior","Alcohol intoxication","Alcoholism","Angina pectoris","Aortocoronary artery bypass graft","Bipolar disorder","Cardiovascular event risk","Depressive disorder","Feeling agitated","Hostile behavior","Mood swings","Nausea","Peripheral vascular disease","Schizophrenia","Suicidal thoughts"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":{"chemblId":"CHEMBL6067972","moleculeType":"Small molecule","molecularWeight":"361.35"},"aliases":["varenicline tartrate","Chantix"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":null,"ecosystem":[],"mechanism":{"target":"Neuronal acetylcholine receptor subunit alpha-7, Neuronal acetylcholine receptor; alpha3/beta4, Neuronal acetylcholine receptor; alpha4/beta2"},"_scrapedAt":"2026-03-28T00:27:13.596Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Smoking cessation assistance","diseaseId":"smoking-cessation-assistance","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT06006143","phase":"PHASE2","title":"Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-06-16","conditions":"Alcohol Use Disorder, Hiv, Tobacco Use Disorder","enrollment":30},{"nctId":"NCT07487818","phase":"PHASE2, PHASE3","title":"A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation","status":"NOT_YET_RECRUITING","sponsor":"Mayo Clinic","startDate":"2026-04-15","conditions":"Smoking Cessation","enrollment":150},{"nctId":"NCT06582888","phase":"EARLY_PHASE1","title":"Advancing VR-based Attentional Bias as a Biomarker for Tobacco Use Disorder","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2024-11-19","conditions":"Nicotine Addiction, Craving","enrollment":200},{"nctId":"NCT06966362","phase":"PHASE4","title":"Varenicline for Smoking Reduction in Veterans Not Ready To Quit","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-07-01","conditions":"Veterans, Tobacco Use Disorder, Cigarette Smoking","enrollment":400},{"nctId":"NCT06118502","phase":"NA","title":"A Clinical Trial of Adaptive Treatment for Early Smoking Cessation Relapse","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-03-25","conditions":"Cigarette Smoking, Smoking Behaviors, Treatment","enrollment":544},{"nctId":"NCT06832085","phase":"PHASE4","title":"Combination Nicotine Replacement Therapy, Cytisine, or Varenicline for Smoking Cessation","status":"RECRUITING","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2025-04-30","conditions":"Tobacco","enrollment":150},{"nctId":"NCT05192837","phase":"NA","title":"Preoperative Smoking Cessation in Patients Undergoing Surgery","status":"TERMINATED","sponsor":"Luzerner Kantonsspital","startDate":"2022-09-02","conditions":"Smoking Cessation, Smoking Reduction, Surgery--Complications","enrollment":251},{"nctId":"NCT04798664","phase":"NA","title":"Comparing Smoking Cessation Interventions Among Underserved Patients Referred for Lung Cancer Screening","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2021-05-17","conditions":"Smoking Cessation","enrollment":3228},{"nctId":"NCT07099638","phase":"PHASE2","title":"Trial of Varenicline With Nicotine Lozenges and a Smartphone Medication Adherence Intervention for Smoking Cessation","status":"NOT_YET_RECRUITING","sponsor":"University of Oklahoma","startDate":"2026-03","conditions":"Smoking Cessation","enrollment":496},{"nctId":"NCT04525755","phase":"PHASE1, PHASE2","title":"STARS (Smoking Treatment And Remote Sampling) Study","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2021-02-08","conditions":"Smoking, Smoking Cessation, Tobacco Smoking","enrollment":652},{"nctId":"NCT02162849","phase":"PHASE4","title":"Reward Sensitivity and Pharmacotherapy for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-12-14","conditions":"Tobacco Use Cessation","enrollment":204},{"nctId":"NCT02271919","phase":"PHASE4","title":"Varenicline and Combined NRT for Smoking Cessation","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-05-14","conditions":"Cigarette Smoker, Tobacco Use Disorder","enrollment":631},{"nctId":"NCT04634071","phase":"PHASE2","title":"Tobacco Treatment Optimization and Preferences During Concurrent Cancer Treatment","status":"COMPLETED","sponsor":"Joseph Valentino, MD","startDate":"2021-01-12","conditions":"Smoking Cessation, Cancer, Treatment-Related","enrollment":126},{"nctId":"NCT05997225","phase":"PHASE4","title":"Tobacco Cessation at FDNY","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2024-05-31","conditions":"Tobacco Use, Tobacco Smoking, Tobacco Use Cessation","enrollment":23},{"nctId":"NCT06442514","phase":"NA","title":"Pain and Smoking Study - Interactive Voice Response","status":"NOT_YET_RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2026-03-30","conditions":"Smoking, Pain, Smoking Cessation","enrollment":220},{"nctId":"NCT04889638","phase":"NA","title":"Tobacco Cessation in Public Housing","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2024-04-03","conditions":"Smoking Cessation, Smoking Reduction, Smoking, Tobacco","enrollment":18},{"nctId":"NCT07145866","phase":"PHASE4","title":"Varenicline and Accelerated Transcranial Magnetic Stimulation (TMS) for Quitting Nicotine Use (Pilot Study)","status":"NOT_YET_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2026-03-15","conditions":"Nicotine Dependence, Transcranial Magnetic Stimulation, Vaping","enrollment":30},{"nctId":"NCT06883162","phase":"PHASE3","title":"Cannabis-Tobacco Co-Use Treatment Study","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-05-06","conditions":"Tobacco Use Disorder, Tobacco Use Cessation, Cannabis Use","enrollment":200},{"nctId":"NCT05694637","phase":"PHASE4","title":"Botswana Smoking and Abstinence Reinforcement Trial","status":"ENROLLING_BY_INVITATION","sponsor":"University of Maryland, Baltimore","startDate":"2023-07-25","conditions":"Smoking Cessation, Hiv","enrollment":750},{"nctId":"NCT05642715","phase":"NA","title":"Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes","status":"RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2024-04-04","conditions":"Hiv, Tobacco Use","enrollment":400},{"nctId":"NCT03227679","phase":"NA","title":"Metabolism-informed Care for Smoking Cessation","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2016-05-18","conditions":"Tobacco Use, Tobacco Use Cessation","enrollment":82},{"nctId":"NCT06854406","phase":"PHASE1","title":"A Study of Varenicline in the Treatment of Visceral Sensation","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2025-06-01","conditions":"Irritable Bowel Syndrome","enrollment":8},{"nctId":"NCT04490057","phase":"PHASE4","title":"A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV","status":"COMPLETED","sponsor":"Yale University","startDate":"2020-07-27","conditions":"Tobacco Use Cessation","enrollment":323},{"nctId":"NCT05703672","phase":"PHASE3","title":"Switching to E-cigarettes in Smokers Not Interested in Quitting","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2023-07-17","conditions":"Smoking Reduction","enrollment":500},{"nctId":"NCT03630614","phase":"PHASE3","title":"Randomized Trial of Electronic Cigarettes With or Without Nicotine in Smoking Cessation.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2018-10-17","conditions":"Smoking Cessation, Smoking, Cigarette, Electronic Cigarette","enrollment":650},{"nctId":"NCT07040566","phase":"PHASE2","title":"A Trial of Varenicline for E-cigarette Cessation","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-10-14","conditions":"E-cigarette Use, Vaping, Nicotine Dependence","enrollment":326},{"nctId":"NCT04176172","phase":"PHASE3","title":"Optimizing Tobacco Use Treatment for PLWHA","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2020-02-17","conditions":"HIV/AIDS, Nicotine Dependence","enrollment":340},{"nctId":"NCT04590404","phase":"PHASE3","title":"Metabolism Informed Smoking Treatment: The MIST RCT","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2020-11-17","conditions":"Smoking","enrollment":606},{"nctId":"NCT06780215","phase":"PHASE2","title":"Efficacy of Varenicline Tartrate in Treating Frequent Premature Ventricular Contractions","status":"COMPLETED","sponsor":"Yihan Chen","startDate":"2025-02-17","conditions":"Premature Ventricular Contraction (PVC)","enrollment":116},{"nctId":"NCT01098955","phase":"EARLY_PHASE1","title":"Smoking Cessation Treatment for Head & Neck Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-03-24","conditions":"Head and Neck Cancer, Smoking Cessation","enrollment":51},{"nctId":"NCT07171112","phase":"PHASE2","title":"Smoking Cessation Trial in Recurrent Acute Pancreatitis and Chronic Pancreatitis","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-11-06","conditions":"Pancreatitis, Chronic, Pancreatitis, Acute, Recurrent Acute Pancreatitis","enrollment":45},{"nctId":"NCT06474299","phase":"PHASE4","title":"The Avenues Study: Dual Use Cessation","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2024-09-24","conditions":"Smoking Cessation, Electronic Cigarette Use","enrollment":500},{"nctId":"NCT06218823","phase":"PHASE4","title":"Tobacco Treatment Comparison for Cancer Care","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2024-03-01","conditions":"Smoking Cessation, Cancer","enrollment":52},{"nctId":"NCT04445662","phase":"NA","title":"Financial Incentives for Homeless Smokers: A Community-based RCT","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2021-06-10","conditions":"Tobacco Smoking","enrollment":184},{"nctId":"NCT03059940","phase":"EARLY_PHASE1","title":"Smoking Cessation Intervention During Low Dose CT (LDCT) Screening for Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2017-06-16","conditions":"Smoking Cessation","enrollment":630},{"nctId":"NCT04604509","phase":"PHASE4","title":"Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial","status":"RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2020-08-04","conditions":"Cigarette Smoking-Related Carcinoma","enrollment":2010},{"nctId":"NCT03262662","phase":"PHASE3","title":"EVarQuit: Extended Pre-quit Varenicline to Assist in Quitting Smoking","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2017-10-01","conditions":"Tobacco Smoking","enrollment":320},{"nctId":"NCT04199117","phase":"PHASE4","title":"Health Systems Reach Interventions Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-03-11","conditions":"Smoking, Cigarette, Smoking Cessation","enrollment":210},{"nctId":"NCT04694846","phase":"NA","title":"Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2020-08-19","conditions":"Lung Non-Small Cell Carcinoma, Head and Neck Squamous Cell Carcinoma","enrollment":19},{"nctId":"NCT06029907","phase":"PHASE4","title":"Project HOPES: Healthy Options for Pain and Ending Smoking. A Program for Cancer Survivors.","status":"COMPLETED","sponsor":"Duke University","startDate":"2024-07-15","conditions":"Smoking Cessation, Pain","enrollment":19},{"nctId":"NCT04725617","phase":"NA","title":"Wellness Intervention for Smoking and HIV","status":"RECRUITING","sponsor":"University of Arizona","startDate":"2021-11-16","conditions":"HIV, Sleep, Smoking Cessation","enrollment":200},{"nctId":"NCT06582693","phase":"NA","title":"Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network","status":"RECRUITING","sponsor":"Children's Hospital of Philadelphia","startDate":"2024-09-06","conditions":"Smoking, Smoking Cessation, Second Hand Tobacco Smoke","enrollment":3200},{"nctId":"NCT03670316","phase":"PHASE4","title":"Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2020-08-17","conditions":"HIV, AIDS, Smoking Cessation","enrollment":378},{"nctId":"NCT06798324","phase":"PHASE4","title":"tDCS Plus Varenicline for Smoking Cessation","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2025-03-10","conditions":"Nicotine Dependence, Tobacco Smoking, Smoking Cessation","enrollment":160},{"nctId":"NCT04198116","phase":"PHASE2","title":"Combining Varenicline and Guanfacine for Smoking Cessation","status":"COMPLETED","sponsor":"Yale University","startDate":"2020-11-01","conditions":"Smoking Cessation","enrollment":165},{"nctId":"NCT06373679","phase":"NA","title":"Switch or Quit R01","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2024-07-10","conditions":"Cigarette Smoking, Smoking Behaviors","enrollment":225},{"nctId":"NCT04188873","phase":"PHASE4","title":"Cessation Screening Project","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2020-12-10","conditions":"Nicotine Dependence","enrollment":529},{"nctId":"NCT06456242","phase":"NA","title":"Contingency Management to Promote Smoking Cessation","status":"RECRUITING","sponsor":"University of Kansas Medical Center","startDate":"2024-09-20","conditions":"Smoking Cessation","enrollment":20},{"nctId":"NCT06688539","phase":"PHASE4","title":"E-cigarette Cessation in Adults Who Co-use Cannabis","status":"RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2025-02-19","conditions":"Nicotine Dependence, Tobacco Use Disorder","enrollment":105},{"nctId":"NCT05413122","phase":"PHASE2, PHASE3","title":"Evaluating Smoking Cessation Interventions for PWH in South Africa","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-11-27","conditions":"Smoking Cessation, HIV, Comorbidities and Coexisting Conditions","enrollment":660},{"nctId":"NCT02424188","phase":"NA","title":"Trial of Integrated Smoking Cessation, Exercise and Weight Management in Serious Mental Illness: TRIUMPH","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2016-07-07","conditions":"Mental Illness","enrollment":192},{"nctId":"NCT01926041","phase":"NA","title":"The Effectiveness of Smoking Cessation in Prediabetic Smokers","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2013-08-01","conditions":"Diabetes Mellitus, Cigarette Smoking, Prediabetes","enrollment":589},{"nctId":"NCT04228965","phase":"PHASE4","title":"Cannabis and Tobacco Co-use Study","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-01-28","conditions":"Tobacco Use Disorder","enrollment":181},{"nctId":"NCT05786547","phase":"PHASE3","title":"V+PSF-M for Tobacco Cessation in HIV Care in India","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-01-02","conditions":"Human Immunodeficiency Virus, Smoking Cessation, Smoking, Tobacco","enrollment":400},{"nctId":"NCT06609369","phase":"PHASE2","title":"Neural Mechanisms Connecting Deficient Sleep and Smoking Relapse","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-04-21","conditions":"Tobacco Use, Tobacco Cessation, Insomnia","enrollment":114},{"nctId":"NCT06751927","phase":"NA","title":"New Strategies to Enhance Smoking Cessation","status":"RECRUITING","sponsor":"University of Chicago","startDate":"2025-04-24","conditions":"Smoking Cessation","enrollment":94},{"nctId":"NCT04738643","phase":"NA","title":"Improving Tobacco Treatment Rates for Cancer Patients Who Smoke","status":"COMPLETED","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2022-06-28","conditions":"Cancer, Tobacco Use, Smoking","enrollment":685},{"nctId":"NCT05918406","phase":"PHASE4","title":"Phase 4 Study Evaluating the Safety of the Nasal Guide With Tyrvaya","status":"COMPLETED","sponsor":"Oyster Point Pharma, Inc.","startDate":"2023-06-14","conditions":"Dry Eye, Keratoconjunctivitis Sicca","enrollment":30},{"nctId":"NCT06027840","phase":"PHASE1","title":"Concurrent vs. Sequential Cessation of Dual Cigarette and E-cigarette Use","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-04-01","conditions":"Cigarette Smoking, E-Cigarette Use, Smoking Cessation","enrollment":40},{"nctId":"NCT00943618","phase":"PHASE3","title":"Combining Varenicline and Bupropion for Smoking Cessation","status":"COMPLETED","sponsor":"M.D. Anderson Cancer Center","startDate":"2010-05-17","conditions":"Smoking Cessation","enrollment":641},{"nctId":"NCT05257629","phase":"PHASE3","title":"Aggressive Smoking Cessation Trial (ASAP)","status":"RECRUITING","sponsor":"Sir Mortimer B. Davis - Jewish General Hospital","startDate":"2023-02-02","conditions":"Acute Coronary Syndrome, Cardiovascular Diseases","enrollment":798},{"nctId":"NCT05367492","phase":"PHASE4","title":"Varenicline for Nicotine Vaping Cessation in Adolescents","status":"COMPLETED","sponsor":"Massachusetts General Hospital","startDate":"2022-06-22","conditions":"Vaping, Nicotine Dependence","enrollment":261},{"nctId":"NCT06679374","phase":"PHASE2","title":"Reducing Falls With Varenicline in Hypocholinergic Parkinson Disease","status":"RECRUITING","sponsor":"Vikas Kotagal","startDate":"2025-04-09","conditions":"Parkinson Disease","enrollment":102},{"nctId":"NCT02460900","phase":"PHASE3","title":"Optimizing Smoking Cessation for People With HIV/AIDS Who Smoke","status":"COMPLETED","sponsor":"University of Maryland, Baltimore","startDate":"2016-07","conditions":"Smoking, HIV","enrollment":184},{"nctId":"NCT06830967","phase":"NA","title":"Virtual Prehabilitation for Patients Undergoing Abdominal Aortic Aneurysm Repair","status":"NOT_YET_RECRUITING","sponsor":"Nova Scotia Health Authority","startDate":"2025-03-01","conditions":"Abdominal Aortic Aneurysm, Prehabilitation, AAA - Abdominal Aortic Aneurysm","enrollment":20},{"nctId":"NCT04107857","phase":"","title":"Electronic Health Record-Enabled Evidence-Based Smoking Cessation Quality Improvement Implementation Program","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2019-10-02","conditions":"Smoking Cessation","enrollment":1000000},{"nctId":"NCT04654585","phase":"NA","title":"Preference-based Tools for Smoking Cessation Among Disadvantaged Smokers, a Pragmatic Randomised Controlled Trial","status":"COMPLETED","sponsor":"Société de Formation Thérapeutique du Généraliste - Recherche","startDate":"2021-02-26","conditions":"Smoking, Smoking Cessation","enrollment":167},{"nctId":"NCT05541497","phase":"PHASE2","title":"Varenicline for Treatment of E-cigarette Dependence","status":"COMPLETED","sponsor":"Yale University","startDate":"2022-11-04","conditions":"Smoking Cessation","enrollment":40},{"nctId":"NCT05700422","phase":"PHASE4","title":"Nasal Spray Study in Sjogren's Dry Eye Disease","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2023-05-01","conditions":"Sjogren's Syndrome, Dry Eye","enrollment":39},{"nctId":"NCT04083144","phase":"NA","title":"Deep rTMS and Varenicline for Smoking Cessation","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2019-08-22","conditions":"Tobacco Use Disorder, Smoking Cessation","enrollment":50},{"nctId":"NCT04595318","phase":"PHASE4","title":"Varenicline for Co-occurring Cannabis and Tobacco Use","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2015-01","conditions":"Cannabis Dependence, Tobacco Dependence","enrollment":7},{"nctId":"NCT03557294","phase":"PHASE4","title":"Varenicline OTC Trial on Efficacy and Safety","status":"COMPLETED","sponsor":"Arizona State University","startDate":"2018-05-07","conditions":"Tobacco Dependence, Withdrawal Symptoms, Smoking Cessation","enrollment":313},{"nctId":"NCT03365362","phase":"PHASE4","title":"A Trial of Directly Observed and Long-term Varenicline","status":"COMPLETED","sponsor":"Albert Einstein College of Medicine","startDate":"2018-10-25","conditions":"Tobacco Use Disorder, Opioid-use Disorder","enrollment":243},{"nctId":"NCT05294263","phase":"PHASE2","title":"Varenicline for the Treatment of Cannabis and Tobacco Use Disorders in Veterans","status":"WITHDRAWN","sponsor":"VA Office of Research and Development","startDate":"2023-04-17","conditions":"Tobacco Use Disorder, Cannabis Use Disorder","enrollment":""},{"nctId":"NCT05181891","phase":"PHASE2","title":"Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking","status":"RECRUITING","sponsor":"Washington State University","startDate":"2022-07-11","conditions":"Alcohol Use Disorder (AUD), Nicotine Use Disorder","enrollment":205},{"nctId":"NCT04167306","phase":"PHASE2","title":"Varenicline and Bupropion for Alcohol Use Disorder","status":"COMPLETED","sponsor":"Vastra Gotaland Region","startDate":"2019-03-04","conditions":"Alcohol Use Disorder, Alcoholism, Alcohol Dependence","enrollment":388},{"nctId":"NCT01511614","phase":"NA","title":"Nicotine Withdrawal Symptoms and Smoking Relapse","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2013-05-20","conditions":"Nicotine Dependence","enrollment":112},{"nctId":"NCT03235505","phase":"PHASE4","title":"Efficacy and Safety of E-cigarettes for Smoking Cessation in Middle-aged Heavy Smokers","status":"COMPLETED","sponsor":"University of Oulu","startDate":"2018-08-01","conditions":"Smoking Cessation, Electronic Cigarette","enrollment":450},{"nctId":"NCT03059563","phase":"PHASE1","title":"Dopamine D2/D3 Receptor Upregulation by Varenicline in Methamphetamine Users","status":"TERMINATED","sponsor":"University of California, Los Angeles","startDate":"2018-01-11","conditions":"Dopamine D2/3 Receptor Availability, Cognitive Function, Methamphetamine Abuse","enrollment":62},{"nctId":"NCT04957758","phase":"PHASE2","title":"Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy","status":"COMPLETED","sponsor":"Oyster Point Pharma, Inc.","startDate":"2021-06-17","conditions":"Neurotrophic Keratopathy","enrollment":113},{"nctId":"NCT05277207","phase":"PHASE4","title":"Tobacco Cessation Treatment Preferences Among Veteran Smokers","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2022-05-02","conditions":"Tobacco Use","enrollment":30},{"nctId":"NCT04602494","phase":"PHASE4","title":"Varenicline For Nicotine Vaping Cessation In Non Smoker Vaper Adolescents","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2020-12-18","conditions":"Vaping, Nicotine Dependence","enrollment":5},{"nctId":"NCT00727103","phase":"PHASE4","title":"Varenicline Treatment in Alcohol and Nicotine Dependent Patients With Schizophrenia","status":"COMPLETED","sponsor":"State University of New York - Upstate Medical University","startDate":"2008-07","conditions":"Schizophrenia, Schizoaffective Disorder, Alcohol Dependence","enrollment":10},{"nctId":"NCT03722966","phase":"PHASE2","title":"Effectiveness of Combination Varenicline and Oral Nicotine Replacement Therapy (COMBO)","status":"TERMINATED","sponsor":"University of Oklahoma","startDate":"2020-01-07","conditions":"Smoking Cessation","enrollment":34},{"nctId":"NCT05997901","phase":"NA","title":"Helping People Adhere to Their Varenicline Treatment by Co-creating a Conversational Agent: A Feasibility Study","status":"UNKNOWN","sponsor":"Centre for Addiction and Mental Health","startDate":"2022-10-12","conditions":"Medication Adherence, Smoking Cessation","enrollment":40},{"nctId":"NCT03980561","phase":"PHASE2","title":"UH3 Varenicline for Cannabis Use Disorder","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2020-01-31","conditions":"Cannabis Use Disorder","enrollment":174},{"nctId":"NCT01413516","phase":"PHASE2","title":"Varenicline In-Patient Study","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-08","conditions":"Smoking Cessation","enrollment":17},{"nctId":"NCT03920215","phase":"PHASE2, PHASE3","title":"Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease","status":"COMPLETED","sponsor":"Oyster Point Pharma, Inc.","startDate":"2018-08-15","conditions":"Long Term Follow up Dry Eye Disease","enrollment":101},{"nctId":"NCT03691350","phase":"EARLY_PHASE1","title":"Bronchoscopy in Determining the Effect of E-Cigarette Smoking on Biomarkers in the Lungs","status":"UNKNOWN","sponsor":"Ohio State University Comprehensive Cancer Center","startDate":"2018-09-17","conditions":"Cigarette Smoker, Current Every Day Smoker","enrollment":239},{"nctId":"NCT01092702","phase":"PHASE2, PHASE3","title":"Varenicline For Smokers In Recovery From Alcohol Dependence","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2008-04","conditions":"Tobacco Abstinence","enrollment":32},{"nctId":"NCT04249882","phase":"PHASE2","title":"A Novel Human Lab Model for Screening AUD Medications","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2020-01-28","conditions":"Alcohol Use Disorder","enrollment":53},{"nctId":"NCT05198271","phase":"NA","title":"Effect of Controlling Environmental Risk Factors in Established RA","status":"UNKNOWN","sponsor":"University Hospital, Montpellier","startDate":"2022-05-31","conditions":"Rheumatoid Arthritis","enrollment":25},{"nctId":"NCT03497299","phase":"PHASE2","title":"Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia","status":"WITHDRAWN","sponsor":"Centre for Addiction and Mental Health","startDate":"2018-07-01","conditions":"Tobacco Use Disorder, Schizophrenia, Cognitive Functioning","enrollment":""},{"nctId":"NCT04717544","phase":"NA","title":"Embedding Comprehensive Smoking Cessation Programs Into Community Clinics","status":"COMPLETED","sponsor":"Friends Research Institute, Inc.","startDate":"2019-10-01","conditions":"Smoking Cessation","enrollment":406},{"nctId":"NCT04135937","phase":"PHASE4","title":"Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH)","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2019-11-18","conditions":"Human Immunodeficiency Virus, Smoking","enrollment":12},{"nctId":"NCT01290445","phase":"","title":"Varenicline Pregnancy Cohort Study","status":"COMPLETED","sponsor":"Pfizer","startDate":"2007-09-13","conditions":"Malformations","enrollment":885185},{"nctId":"NCT04011280","phase":"PHASE4","title":"Novel Pharmacotherapy Approaches in Smokers With Serious Mental Illness","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2019-08-12","conditions":"Bipolar Disorder, Schizophrenia, Schizoaffective Disorder","enrollment":39},{"nctId":"NCT05082974","phase":"PHASE3","title":"Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)","status":"COMPLETED","sponsor":"Vance Thompson Vision ND","startDate":"2021-10-20","conditions":"Dry Eye Disease","enrollment":40},{"nctId":"NCT05576415","phase":"PHASE1","title":"Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease","status":"COMPLETED","sponsor":"Corxel Pharmaceuticals","startDate":"2022-12-07","conditions":"Dry Eye Disease","enrollment":9},{"nctId":"NCT05378945","phase":"PHASE3","title":"Clinical Trial to Evaluate the Efficacy and Safety of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease","status":"COMPLETED","sponsor":"Corxel Pharmaceuticals","startDate":"2022-07-22","conditions":"Dry Eye Disease","enrollment":340}],"_emaApprovals":[],"_faersSignals":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[],"developmentCodes":[],"ownershipHistory":[],"publicationCount":63,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Champix","genericName":"Champix","companyName":"The Queen Elizabeth Hospital","companyId":"the-queen-elizabeth-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}